{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T19:29:58Z","timestamp":1789586998384,"version":"build-2803163510"},"reference-count":30,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T00:00:00Z","timestamp":1235865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2009,3]]},"DOI":"10.1016\/j.vaccine.2008.09.028","type":"journal-article","created":{"date-parts":[[2008,10,2]],"date-time":"2008-10-02T09:00:06Z","timestamp":1222938006000},"page":"1771-1776","source":"Crossref","is-referenced-by-count":26,"title":["Immunity of cattle following vaccination with a Mannheimia haemolytica chimeric PlpE\u2013LKT (SAC89) protein"],"prefix":"10.1016","volume":"27","author":[{"given":"A.W.","family":"Confer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Ayalew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Montelongo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.L.","family":"Step","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.H.","family":"Wray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.D.","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.J.","family":"Panciera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.vaccine.2008.09.028_bib1","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1017\/S1466252307001375","article-title":"Mannheimia haemolytica and bovine respiratory disease","volume":"8","author":"Rice","year":"2007","journal-title":"Anim Health Res Rev"},{"issue":"1","key":"10.1016\/j.vaccine.2008.09.028_bib2","first-page":"30","article-title":"Vaccination of calves with leukotoxic culture supernatant from Pasteurella haemolytica","volume":"52","author":"Shewen","year":"1988","journal-title":"Can J Vet Res"},{"issue":"3\u20134","key":"10.1016\/j.vaccine.2008.09.028_bib3","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/0378-1135(93)90034-5","article-title":"Immunogens of Pasteurella","volume":"37","author":"Confer","year":"1993","journal-title":"Vet Microbiol"},{"issue":"21\u201322","key":"10.1016\/j.vaccine.2008.09.028_bib4","doi-asserted-by":"crossref","first-page":"2821","DOI":"10.1016\/S0264-410X(03)00213-5","article-title":"Immunogenicity of recombinant Mannheimia haemolytica serotype 1 outer membrane protein PlpE and augmentation of a commercial vaccine","volume":"21","author":"Confer","year":"2003","journal-title":"Vaccine"},{"issue":"13","key":"10.1016\/j.vaccine.2008.09.028_bib5","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1016\/j.vaccine.2005.11.036","article-title":"Recombinant Mannheimia haemolytica serotype 1 outer membrane protein PlpE enhances commercial M. haemolytica vaccine-induced resistance against serotype 6 challenge","volume":"24","author":"Confer","year":"2006","journal-title":"Vaccine"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2008.09.028_bib6","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0165-2427(94)05390-E","article-title":"Serum antibody responses of cattle to iron-regulated outer membrane proteins of Pasteurella haemolytica A1","volume":"47","author":"Confer","year":"1995","journal-title":"Vet Immunol Immunopathol"},{"issue":"2","key":"10.1016\/j.vaccine.2008.09.028_bib7","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.jbiotec.2008.03.006","article-title":"Expression of a modified Mannheimia haemolytica GS60 outer membrane lipoprotein in transgenic alfalfa for the development of an edible vaccine against bovine pneumonic pasteurellosis","volume":"135","author":"Lee","year":"2008","journal-title":"J Biotechnol"},{"issue":"7","key":"10.1016\/j.vaccine.2008.09.028_bib8","doi-asserted-by":"crossref","first-page":"875","DOI":"10.2460\/ajvr.1995.56.07.875","article-title":"Vaccination of cattle with outer membrane protein-enriched fractions of Pasteurella haemolytica and resistance against experimental challenge exposure","volume":"56","author":"Morton","year":"1995","journal-title":"Am J Vet Res"},{"issue":"3","key":"10.1016\/j.vaccine.2008.09.028_bib9","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1128\/IAI.57.3.711-716.1989","article-title":"Pasteurella haemolytica antigens associated with resistance to pneumonic pasteurellosis","volume":"57","author":"Mosier","year":"1989","journal-title":"Infect Immun"},{"issue":"12","key":"10.1016\/j.vaccine.2008.09.028_bib10","doi-asserted-by":"crossref","first-page":"5613","DOI":"10.1128\/IAI.66.12.5613-5619.1998","article-title":"Genetic and immunologic analysis of PlpE, a lipoprotein important in complement-mediated killing of Pasteurella haemolytica Serotype 1","volume":"66","author":"Pandher","year":"1998","journal-title":"Infect Immun"},{"issue":"3","key":"10.1016\/j.vaccine.2008.09.028_bib11","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0378-1135(98)00293-4","article-title":"Identification of immunogenic, surface-exposed outer membrane proteins of Pasteurella haemolytica serotype 1","volume":"65","author":"Pandher","year":"1999","journal-title":"Vet Microbiol"},{"issue":"12","key":"10.1016\/j.vaccine.2008.09.028_bib12","doi-asserted-by":"crossref","first-page":"7265","DOI":"10.1128\/IAI.72.12.7265-7274.2004","article-title":"Characterization of immunodominant and potentially protective epitopes of Mannheimia haemolytica serotype 1 outer membrane lipoprotein PlpE","volume":"72","author":"Ayalew","year":"2004","journal-title":"Infect Immun"},{"issue":"3\u20134","key":"10.1016\/j.vaccine.2008.09.028_bib13","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.vetmic.2005.11.067","article-title":"Sequence diversity of the immunogenic outer membrane lipoprotein PlpE from Mannheimia haemolytica serotypes 1, 2 and 6","volume":"114","author":"Ayalew","year":"2006","journal-title":"Vet Microbiol"},{"issue":"9","key":"10.1016\/j.vaccine.2008.09.028_bib14","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1099\/00221287-142-9-2499","article-title":"Characterization of epitopes involved in the neutralization of Pasteurella haemolytica serotype A1 leukotoxin","volume":"142","author":"Lainson","year":"1996","journal-title":"Microbiology"},{"issue":"32","key":"10.1016\/j.vaccine.2008.09.028_bib15","doi-asserted-by":"crossref","first-page":"4842","DOI":"10.1016\/S0264-410X(01)00226-2","article-title":"Bordetella bronchiseptica fimbrial protein-enhanced immunogenicity of a Mannheimia haemolytica leukotoxin fragment","volume":"19","author":"Rajeev","year":"2001","journal-title":"Vaccine"},{"issue":"38","key":"10.1016\/j.vaccine.2008.09.028_bib16","doi-asserted-by":"crossref","first-page":"4955","DOI":"10.1016\/j.vaccine.2008.07.023","article-title":"Mannheimia haemolytica chimeric protein vaccine composed of the major surface-exposed epitope of outer membrane lipoprotein PlpE and the neutralizing epitope of leukotoxin","volume":"26","author":"Ayalew","year":"2008","journal-title":"Vaccine"},{"issue":"12\u201313","key":"10.1016\/j.vaccine.2008.09.028_bib17","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/S0264-410X(97)84247-8","article-title":"Serum antibody responses of cattle vaccinated with partially purified native Pasteurella haemolytica leukotoxin","volume":"15","author":"Confer","year":"1997","journal-title":"Vaccine"},{"issue":"20","key":"10.1016\/j.vaccine.2008.09.028_bib18","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1016\/S0264-410X(98)00115-7","article-title":"Duration of serum antibody responses following vaccination and revaccination of cattle with non-living commercial Pasteurella haemolytica vaccines","volume":"16","author":"Confer","year":"1998","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.vaccine.2008.09.028_bib19","first-page":"2532","article-title":"Bovine pneumonic pasteurellosis: model for Pasteurella haemolytica- and Pasteurella multocida-induced pneumonia in cattle","volume":"45","author":"Panciera","year":"1984","journal-title":"Am J Vet Res"},{"issue":"12","key":"10.1016\/j.vaccine.2008.09.028_bib20","first-page":"2538","article-title":"Bovine pneumonic pasteurellosis: effect of vaccination with live Pasteurella species","volume":"45","author":"Panciera","year":"1984","journal-title":"Am J Vet Res."},{"key":"10.1016\/j.vaccine.2008.09.028_bib21","series-title":"Statistics for veterinary and animal science, vols. 96\u201398","author":"Petrie","year":"1999"},{"issue":"2","key":"10.1016\/j.vaccine.2008.09.028_bib22","first-page":"342","article-title":"Effect of vaccination with live or killed Pasteurella haemolytica on resistance to experimental bovine pneumonic pasteurellosis","volume":"46","author":"Confer","year":"1985","journal-title":"Am J Vet Res"},{"issue":"2","key":"10.1016\/j.vaccine.2008.09.028_bib23","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1046\/j.1365-2567.1998.00423.x","article-title":"Low antigen dose favours selection of somatic mutants with hallmarks of antibody affinity maturation","volume":"93","author":"Gonz\u00e1lez-Fern\u00e1ndez","year":"1998","journal-title":"Immunology"},{"issue":"1","key":"10.1016\/j.vaccine.2008.09.028_bib24","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.vaccine.2006.07.018","article-title":"Dose-response to type V group B streptococcal polysaccharide-tetanus toxoid conjugate vaccine in healthy adults","volume":"25","author":"Baker","year":"2007","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2008.09.028_bib25","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1073\/pnas.92.5.1257","article-title":"Early high-affinity neutralizing anti-viral IgG responses without further overall improvements of affinity","volume":"92","author":"Roost","year":"1995","journal-title":"Proc Natl Acad Sci USA."},{"issue":"35","key":"10.1016\/j.vaccine.2008.09.028_bib26","doi-asserted-by":"crossref","first-page":"4375","DOI":"10.1016\/j.vaccine.2005.04.022","article-title":"Synthetic peptide vaccination in cattle: induction of strong cellular immune responses against peptides derived from the Mycobacterium bovis antigen Rv3019c","volume":"23","author":"Vordermeier","year":"2005","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2008.09.028_bib27","first-page":"463","article-title":"A comparison of 2 vaccination programs in feedlot calves at ultra-high risk of developing undifferentiated fever\/bovine respiratory disease","volume":"49","author":"Wildman","year":"2008","journal-title":"Can Vet J"},{"issue":"1","key":"10.1016\/j.vaccine.2008.09.028_bib28","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/0378-1135(91)90107-Q","article-title":"Immunopotentiation of cattle vaccinated with a soluble Brucella abortus antigen with low LPS content: an analysis of cellular and humoral immune responses","volume":"29","author":"Dzata","year":"1991","journal-title":"Vet Microbiol"},{"issue":"1","key":"10.1016\/j.vaccine.2008.09.028_bib29","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0378-1135(91)90108-R","article-title":"The effects of adjuvants on immune responses in cattle injected with a Brucella abortus soluble antigen","volume":"29","author":"Dzata","year":"1991","journal-title":"Vet Microbiol"},{"issue":"5","key":"10.1016\/j.vaccine.2008.09.028_bib30","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/0923-2494(92)80060-X","article-title":"DDA as an immunological adjuvant","volume":"143","author":"Hilgers","year":"1992","journal-title":"Res Immunol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X08012358?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X08012358?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T05:35:01Z","timestamp":1709271301000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X08012358"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3]]},"references-count":30,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2009,3]]}},"alternative-id":["S0264410X08012358"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2008.09.028","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,3]]}}}